| Lee, Stephanie J |
NCT04572815: Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant |
|
|
| Recruiting | 2 | 116 | US | Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Ustekinumab, CNTO 1275, CNTO1275, Immunoglobulin G1, Anti-(Human Interleukin-12 Subunit beta (IL-12B, CLMF p40, NKSF2)) (Human Monoclonal CNTO 1275 gamma1-chain), Disulfide with Human Monoclonal CNTO 1275 kappa-chain, Dimer, Stelara | Fred Hutchinson Cancer Center | Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm | 03/26 | 09/27 | | |
NCT04198922: Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease |
|
|
| Recruiting | 2 | 50 | US | Acalabrutinib, 1420477-60-6, ACP-196, Benzamide, Bruton Tyrosine Kinase Inhibitor ACP-196, Questionnaire Administration | Fred Hutchinson Cancer Center, AstraZeneca | Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm | 12/25 | 01/27 | | |
NCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease |
|
|
| Recruiting | 2 | 82 | US | Belumosudil, KD 025, KD-025, KD025, Rho-associated Coiled-coil Kinase 2 Inhibitor KD025, ROCK-II Inhibitor KD025, ROCK2 Inhibitor KD025, SLx 2119, SLx-2119, SLx2119, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Electronic Health Record Review, Placebo Administration | Fred Hutchinson Cancer Center, Sanofi | Chronic Graft Versus Host Disease | 05/27 | 12/27 | | |
NCT04111497: Glasdegib for Chronic Graft-Versus-Host Disease |
|
|
| Terminated | 1/2 | 15 | US | Glasdegib, 1095173-27-5, PF 04449913, PF-04449913, PF04449913 | Fred Hutchinson Cancer Center, Pfizer | Chronic Graft Versus Host Disease, Fasciitis | 08/23 | 08/23 | | |
| Active, not recruiting | N/A | 601 | US | | Fred Hutchinson Cancer Center, University of Minnesota, Stanford University, Dana-Farber Cancer Institute, Vanderbilt University, Medical College of Wisconsin, Washington University School of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Chronic Graft Versus Host Disease | 05/17 | 02/26 | | |
| Active, not recruiting | N/A | 383 | US | | Fred Hutchinson Cancer Center | Graft vs Host Disease | 09/19 | 02/26 | | |
PROHIBIT-ICH, NCT03863665: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage |
|
|
| Terminated | N/A | 86 | Europe | A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci | University College, London, University of Oxford, The Stroke Association, United Kingdom | Intracerebral Hemorrhage | 05/22 | 04/23 | | |
NCT06202677: Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms |
|
|
| Active, not recruiting | N/A | 225 | RoW | Self-guided program on obsessive compulsive disorder, Self-guided program on cooperation | National University of Singapore, Intellect Pte. Ltd. | Obsessive-Compulsive Disorder | 03/24 | 07/24 | | |
| Active, not recruiting | N/A | 1753 | US | Donor Search Prognosis Score | Center for International Blood and Marrow Transplant Research, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program, Medical College of Wisconsin | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Acquired Aplastic Anemia, Sickle Cell Disease | 06/24 | 03/25 | | |
| Active, not recruiting | N/A | 273 | US | Biospecimen Collection, Optical Coherence Tomography, OCT, Spirometry, Survey Administration, Digital Photography, Quality-of-Life Assessment, Quality of Life Assessment, Medical Chart Review, Chart Review | Fred Hutchinson Cancer Center, National Cancer Institute (NCI), National Institutes of Health (NIH) | Hematopoietic and Lymphoid Cell Neoplasm | 10/25 | 10/25 | | |
NCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study |
|
|
| Recruiting | N/A | 200 | Canada, US | Biospecimen Collection, Medical Chart Review, Chart Review, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Chronic Graft Versus Host Disease | 08/26 | 08/26 | | |
| Eichenfield, Lawrence F |
| Recruiting | N/A | 15000 | Europe, Canada, US | | Target PharmaSolutions, Inc. | Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria | 12/50 | 12/50 | | |
| Mesinkovska, Natasha |
| Recruiting | 2 | 68 | US | Dupilumab, Placebo | Emma Guttman, Regeneron Pharmaceuticals | Alopecia Areata | 12/26 | 12/27 | | |
NCT05866562: Dupilumab in the Treatment of Pediatric Alopecia Areata |
|
|
| Recruiting | 2 | 76 | US | Dupilumab, Dupixent, Placebo | Icahn School of Medicine at Mount Sinai | Alopecia Areata | 05/28 | 05/29 | | |
NCT04176068: Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration |
|
|
| Completed | 1 | 20 | US | calcium hydroxylapatite (Radiesse) and IFUS (Ulthera), intense microfocused ultrasound | University of California, Irvine | Skin Laxity | 12/21 | 12/21 | | |
NCT04800185: Characterizing Skin Microbiome Change in Atopic Dermatitis |
|
|
| Completed | 1 | 20 | US | Crisaborole 2% Top Oint, Skin Microbiome Swabs | University of California, Irvine, Pfizer | Atopic Dermatitis, Atopic Dermatitis Eczema | 04/22 | 04/22 | | |
NCT04969380: SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow |
|
|
| Completed | N/A | 20 | US | Sofwave | Sofwave Medical LTD | Skin Laxity | 02/23 | 02/23 | | |
NCT04530500: COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression |
|
|
| Withdrawn | N/A | 200 | US | COVID-19 Androgen Sensitivity Test (CoVAST) | University of California, Irvine, Applied Biology, Inc. | Covid19, Androgen Receptor Gene Overexpression | 12/21 | 12/23 | | |
| Recruiting | N/A | 15000 | Europe, Canada, US | | Target PharmaSolutions, Inc. | Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria | 12/50 | 12/50 | | |
| Haft, Michael |
| Recruiting | N/A | 15000 | Europe, Canada, US | | Target PharmaSolutions, Inc. | Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria | 12/50 | 12/50 | | |
| Kellogg, Caitlyn |
| Recruiting | N/A | 15000 | Europe, Canada, US | | Target PharmaSolutions, Inc. | Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria | 12/50 | 12/50 | | |
